N头条>英语词典>recombinant DNA technology翻译和用法

recombinant DNA technology

美 [rɪˈkɑmbɪnənt ˌdiː en ˈeɪ tekˈnɑːlədʒi]

网络  DNA重组技术; 技术; 重组DNA技术; 重组; 重组 DNA技术

网络

双语例句

  • Method: Adopting the recombinant DNA technology, the prokaryotic expression plasmids of one normal recombinant and tree single-residue variants of bovine prion protein were constructed.
    【方法】应用DNA重组技术,正确地构建牛朊蛋白基因的1个正常重组朊蛋白和3个单氨基酸变异体的原核表达载体,经转化E。
  • Prophylactic vaccines based on the use of virus-like particles ( VLPs) obtained from auto-assembly of L1 or L1 and L2 proteins produced by recombinant DNA technology are under phase I/ II clinical trials for HPV6/ 11 associated with condylomas.
    通过DNA重组技术,基于HPV6/11型L1或L1和L2蛋白自我组装成病毒样颗粒的研究已经进入了I/II期临床实验。
  • Application of recombinant DNA technology in entomology
    重组DNA技术在昆虫学中的应用
  • The parents of 22 strong heterotic combinations, 'in-which Yiyuan 2, a wheat-rye recombinant was used as male parent, Were tested and analyzed by random amplified polymorphic DNA ( RAPD) markers technology.
    利用RAPD技术对小麦(黑麦)异源重组系异源2号组配的22个强优势杂交组合的亲本进行了遗传差异检测分析。
  • Nesiritide is a synthetic form of brain natriuretic peptide using recombinant DNA technology.
    奈西立肽是利用重组DNA技术得到的合成型人类脑利钠肽。
  • With the development of recombinant DNA and peptide synthesize technology, and advantage in analytical separation technology, more and more proteins and peptides, such as enzyme, activators and inhibitors, poly-and monoclonal antibodies, and various vaccines, are used as pharmaceuticals in clinic.
    随着重组DNA和多肽合成技术的发展,更加之分析分离技术的提高,越来越多的蛋白质和多肽,象酶、活性因子、抑制因子、多克隆与单克隆抗体、疫苗,被作为药物应用于临床。
  • The advent of recombinant DNA technology has provided efficient and cost-effective alternate sources for many therapeutic proteins.
    重组DNA技术为许多治疗性蛋白的生产提供了一种有效的替代方法。
  • Therapeutic recombinant proteins are produced by the recombinant DNA technology.
    重组药用蛋白质是指利用DNA重组技术生产的蛋白质。
  • With the development of recombinant DNA technology and expression system, quantity of known protein increases.
    随着重组DNA技术的发展和表达体系的完善,已知的蛋白质数目有了很大增长。
  • Although we are now able to produce pharmacological peptides by recombinant DNA technology, yet we fail to produce amidated peptides in the same way because bacteria lack the a-amidase.
    尽管我们能够通过重组DNA技术利用细菌生产具有药理活性的蛋白质,然而这种技术却不能用于生产酰胺化多肽,因为细菌中没有α-酰胺化酶。